Diabetes Remission of Any Duration May Reduce Risk of Renal and Cardiovascular Disease:
Remission of T2D, regardless of duration of remission, was associated with reduced risk of diabetes-related CKD and CVD in a post hoc analysis of Look AHEAD.
Newly FDA-Authorized Diabetes Digital Therapeutic Can be Cost-Effective, According to Modeling Study
The digital prescription therapeutic when used along with prescription diabetes therapies, can help reduce the costs of managing the disease and enhance standard of care.
Where is All the Wegovy Going? Highest and Lowest Prescribing States
The GLP-1 RAs Wegovy, Ozempic, Mounjaro, and Zepbound have taken up more real estate on the US map in some areas than others. Click to find out more.
Vaccination Provides Moderate Protection against Long COVID in Children
Vaccination against SARS-CoV-2 was associated with reduced risk of long COVID for at least 12 months in children and adolescents in a new large retrospective study.
Vaccination Snapshots: COVID-19 and Beyond
Click through a short slideshow review of the available COVID-19 vaccines for adults and children and of the long COVID symptoms to watch for in all your patients.
Daily Dose: Lack of Osteoporosis Screening, Treatment in Patients with Cirrhosis
Your daily dose of the clinical news you may have missed.
Rapid POC Test for 3 Pediatric Respiratory Viruses: Quick Survey
Tell us what features you would find most valuable in a rapid point-of-care test for simultaneous detection of respiratory viruses in pediatric patients.
Gabapentinoids May Increase Risk of Severe COPD Exacerbations, Warns New Study
In persons with COPD, use of the anticonvulsants was linked to a 39% increase in risk of severe disease exacerbation requiring hospital admission, study authors reported.
Hey Doc: Use or Lose those Vacation Days
Vacation behavior among US physicians was found wanting, with more than half taking less than 15 days/year, 20% taking ≤5 days, and 70% working on their time off.
"Ozempic" and Older Adults: Awareness of & Views on Rx Medications for Weight Management
When it comes overweight, obesity, and prescription drugs for weight loss, these results from the National Poll on Healthy Aging suggest older US adults need guidance.
Top 10 Diets for 2024: US News & World Report Rankings
US News and World Report released its annual “Best Diets” rankings for 2024. Out of 30 of the most popular diets ranked by health experts, these 10 came out on top.
Bempedoic Acid Associated with 20% Reduction in Total CV Events in Prespecified CLEAR Outcomes Analysis
The protective effect of bempedoic acid appeared to increase with the number of CV events a study participant experienced, according to study authors.
Cancer Deaths are Decreasing, but New Cases are Expected to Reach Peak in 2024
Over 4 million cancer deaths have been reverted since 1991, but new cancer cases are estimated to reach over 2 million, according to new data from an annual American Cancer Society report.
Daily Dose: Semaglutide Not Linked to Suicide Ideation
Shelf-Life Extended for Narcan Nasal Spray, FDA Announces
This second shelf-life extension for the OTC naloxone hydrochloride 4 mg spray continues the FDA's campaign to prevent drug overdose and related fatalities.
More Childhood Stress Linked to Increased Risk for Cardiometabolic Disease
Findings from new study suggest that promoting healthy coping strategies for stress during early life can reduce cardiometabolic risk, report researchers.
Daily Dose: Hospitalization for COVID-19 vs for Flu Linked to More Long-Term Outcomes
Nonprescription Weight Loss Products Used by 1 in 10 Adolescents Worldwide: New Meta-Analysis
Use of nonprescribed weight loss products was higher among girls than boys globally and led by diet pills, followed by laxatives and diuretics, a meta-analysis found.
Early Breastfeeding May Reduce Risk of Childhood Obesity, Regardless of Mother's BMI: NIH Study
Each additional month of breastfeeding beyond 3 months correlated with a significantly lower child BMIz, especially for mothers identified as overweight or obese.
Study Reveals Disparities in Inflammatory Bowel Disease Based on Race, Sex, and Immigration Status
Findings showed that IBD phenotype varied by race, although foreign-born participants of all races showed evidence of later onset and milder disease.